%D8%A7%D9%86%D8%AD%D9%84%D8%A7%D9%84_%D8%A7%D9%84%D8%A8%D8%B4%D8%B1%D8%A9_%D8%A7%D9%84%D9%81%D9%82%D8%A7%D8%B9%D9%8AEpiderm%C3%B2lisi_ampul%C2%B7larCategory:Epidermolysis_bullosaEpidermolysis_bullosaEpidermolysis_bullosaEpidermolysis_bullosaEpidermolizo_blazigaEpiderm%C3%B3lisis_ampollar%D8%A8%DB%8C%D9%85%D8%A7%D8%B1%DB%8C_%D9%BE%D8%B1%D9%88%D8%A7%D9%86%D9%87%E2%80%8C%D8%A7%DB%8CEpidermolysis_bullosa%D7%AA%D7%9E%D7%A1_%D7%91%D7%95%D7%A2%D7%AA%D7%99_%D7%A9%D7%9C_%D7%94%D7%A2%D7%95%D7%A8Epidermolisis_bulosaEpidermolisi_bollosaEpidermolysis_bullosaEpidermolysis_bullosaEpidermiolysis_bullosa%E0%AC%8F%E0%AC%AA%E0%AC%BF%E0%AC%A1%E0%AC%B0%E0%AD%8D%E0%AC%AE%E0%AD%8B%E0%AC%B2%E0%AC%BE%E0%AC%87%E0%AC%B8%E0%AC%BF%E0%AC%B8_%E0%AC%AC%E0%AD%81%E0%AC%B2%E0%AD%8B%E0%AC%B8%E0%AC%BEP%C4%99cherzowe_oddzielanie_si%C4%99_nask%C3%B3rkaEpiderm%C3%B3lise_bolhosa%D0%91%D1%83%D0%BB%D0%BB%D1%91%D0%B7%D0%BD%D1%8B%D0%B9_%D1%8D%D0%BF%D0%B8%D0%B4%D0%B5%D1%80%D0%BC%D0%BE%D0%BB%D0%B8%D0%B7Bulozna_epidermoliza%D0%91%D1%83%D0%BB%D0%BE%D0%B7%D0%BD%D0%B0_%D0%B5%D0%BF%D0%B8%D0%B4%D0%B5%D1%80%D0%BC%D0%BE%D0%BB%D0%B8%D0%B7%D0%B0Epidermolysis_bullosa%D0%91%D1%83%D0%BB%D1%8C%D0%BE%D0%B7%D0%BD%D0%B8%D0%B9_%D0%B5%D0%BF%D1%96%D0%B4%D0%B5%D1%80%D0%BC%D0%BE%D0%BB%D1%96%D0%B7Q923020%E8%A1%A8%E7%9A%AE%E6%BA%B6%E8%A7%A3%E6%B0%B4%E7%9A%B0%E7%97%87
about
sameAs
P101
Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis BullosaSafety and Efficacy of Diacerein 1% Ointment Topical Formulation Compared to Placebo for Subjects With Epidermolysis Bullosa Simplex (EBS)Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous KeratinocytesTopical Bercolagene Telserpavec (KB103) Gene Therapy to Restore Functional Collagen VII for the Treatment of Dystrophic Epidermolysis BullosaPhase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis BullosaEfficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis BullosaTreatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral ErythromycinOleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10)Topical QR-313 in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Due to Mutation(s) in Exon 73 of the COL7A1geneInjections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa SimplexIntravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa SimplexStudy of the Nutritional, Metabolic, and Body Composition Profile in Children and Adolescents With Epidermolysis BullosaPregabalin Treatment for RDEB Pain and ItchEvaluation of the Efficacy of ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis BullosaRigosertib for RDEB-SCCA Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)Gene Transfer for Recessive Dystrophic Epidermolysis BullosaBiochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCsA Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not HealingProspective, Longitudinal Natural History Study in Dystrophic Epidermolysis BullosaA Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis BullosaA Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation PatientsEvaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis BullosaGentamicin for RDEBEffect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal SkinOpen Label Extension Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis BullosaStudy of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis BullosaPilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEBObservational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis BullosaShort Term Observational Study in DEB PatientsA Comparative Study of the Healing of Chronic Ulcers of Recessive Epidermolysis Bullosa : Dressing vs Amniotic MembraneTreatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of CareStudy of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling MearaCharacteristics of Patients With Recessive Dystrophic Epidermolysis BullosaTrial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys BullosaTreatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
P1050
P2175
Inherited epidermolysis bullosaInherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 casesProgress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa.Nutritional aspects of children and adolescents with epidermolysis bullosa: literature review.Management of digestive lesions associated to congenital epidermolysis bullosaCultured epidermal stem cells in regenerative medicine.A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases.A nutrition-based approach to epidermolysis bullosa: Causes, assessments, requirements and management
P921
Q61909414-C288E989-EF75-4164-B98C-CDED35A2A749Q61909752-5C91BE4E-029B-4096-B119-169FC90FDDEFQ61966391-63B0B832-BF61-4BBF-B7C0-3FC46978C68EQ62814184-7D661F03-12CF-41F7-9B2E-A05DD5DAF5C2Q63229239-CBAE82E4-0BF6-4F63-BC75-E5A56F899DB8Q63319695-948AFFA3-2A00-4C89-BE61-B53A2DD91663Q63338303-7B56B5CC-F9A5-4183-A520-00A77C23F3FBQ63339412-888A387C-1E2D-4CA8-A3B4-E6735F772DEFQ63394202-FD1F59E9-D8CD-4B98-9FE3-2F93B1DF24AEQ63400589-582B3DDA-17B9-4D7E-B748-53243A7D5493Q63404600-647AE6E2-2085-4694-947B-B571C757C8B2Q63405438-1EBCFAF9-183A-4224-9792-AC24501A1A9DQ63405624-4DFEF616-0575-4A70-BA60-6AD54DB06677Q63572158-40EE004E-E338-40E5-8165-9B89C314F05DQ63587786-C85F6FE2-0BF2-490C-AF91-98BCF1619C85Q63591930-3F374492-FB2F-46EF-B3E4-CA91DEEFD10AQ63595000-C62E3054-276E-49C4-8326-8C099B1E3104Q63817067-9130E338-686A-4956-9B4D-7D8115E8FC83Q63836159-A2BFFD30-4596-466A-9813-4901F14F9413Q63841158-0E1D0CB7-0B84-47EE-8A50-A5BA02F1779AQ63844665-1430FD78-089F-4667-82CB-159992C5A42EQ64122365-EE04B14C-CC5F-451C-89FB-B7983EF3D8F6Q64151304-AB347085-B1FE-4EFD-BABD-52D02953408AQ64172355-694E8BE8-98D2-4F11-9ED6-1CFFC96FB3F0Q64173418-C1F50123-7FAE-47EC-967C-5300027DC875Q64183608-AABACA31-B4F7-4777-8D39-7DB0E59F8485Q64216955-E3553883-6125-4F0D-9AC0-409D282D19ACQ64220697-619CB886-8FF3-4D23-B467-133543E1869FQ64350839-C97306BB-0951-40D6-9EEF-9282F9D095EDQ64351646-F885EC26-D5B0-4A06-8AFD-F0E9680FD976Q64353957-75F33682-8C25-4252-81B1-F467EDCC8782Q64397994-45FF16AD-0E4E-41BA-BA99-AC109F85600BQ64613593-C38CB123-1ED5-4315-925E-7B46EBF97D92Q64614140-2569655D-FDA4-4496-B42C-FFCB0CE8BF28Q64639292-A8D76B7E-EF2A-4C1E-B649-CBEBE87E9C4DQ64645459-70ADD638-7DB7-4AB3-A635-00BD185C1D6DQ64658687-1EAE5936-B135-414D-B1EB-65AE3556F7EBQ64662082-F9CE225A-A132-401A-AC0D-B8C263E7AD3BQ64665035-474CFE8C-33D5-4444-BBC6-11F7AED65806Q64672734-061741CC-C38F-4B09-B10B-8A0748660866
P1050
description
Grave malattia della pelle
@it
Human disease of the skin and mucous membranes
@en
Krankheit
@de
maladie de la peau
@fr
neboli Nemoc motýlích křídel
@cs
Группа заболеваний, при которых кожа тяжело травмируется от минимальных воздействий.
@ru
مرض يصيب الإنسان
@ar
ମାନବ ରୋଗ
@or
name
Bulozna epidermoliza
@sl
Epidermiolysis bullosa
@nb
Epidermolisis bulosa
@id
Epidermolizo blaziga
@eo
Epidermolysis bullosa
@cs
Epidermolysis bullosa
@de
Epidermolysis bullosa
@de-ch
Epidermolysis bullosa
@en-ca
Epidermolysis bullosa
@en-gb
Epidermolysis bullosa
@fi
type
label
Bulozna epidermoliza
@sl
Epidermiolysis bullosa
@nb
Epidermolisis bulosa
@id
Epidermolizo blaziga
@eo
Epidermolysis bullosa
@cs
Epidermolysis bullosa
@de
Epidermolysis bullosa
@de-ch
Epidermolysis bullosa
@en-ca
Epidermolysis bullosa
@en-gb
Epidermolysis bullosa
@fi
altLabel
EB
@en
EB
@nn
Epidermolisis bullosa
@es
Epidermolysis bullosa (disorder)
@en
Epidermolysis bullosa
@en
Pell de papallona
@ca
Pell de vidre
@ca
acantholysis bullosa
@en
bulløs epidermolyse
@nn
butterfly disease
@en
prefLabel
Bulozna epidermoliza
@sl
Epidermiolysis bullosa
@nb
Epidermolisis bulosa
@id
Epidermolizo blaziga
@eo
Epidermolysis bullosa
@cs
Epidermolysis bullosa
@de
Epidermolysis bullosa
@de-ch
Epidermolysis bullosa
@en-ca
Epidermolysis bullosa
@en-gb
Epidermolysis bullosa
@fi
P557
P672
P2581
P486
P508
P646
P1245
P1325
P1417
science/epidermolysis-bullosa
P1461
Epidermolysis-Bullosa